Europe Somatostatin Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Somatostatin Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 0.1 mg Market Performance (Volume)
  • 2.1.2 0.25 mg Market Performance (Volume)
  • 2.1.3 0.6 mg Market Performance (Volume)
  • 2.1.4 2 mg Market Performance (Volume)
  • 2.1.5 3 mg Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 0.1 mg Market Performance (Value)
  • 2.1.2 0.25 mg Market Performance (Value)
  • 2.1.3 0.6 mg Market Performance (Value)
  • 2.1.4 2 mg Market Performance (Value)
  • 2.1.5 3 mg Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Cancer Market Performance (Volume)
  • 3.1.2 Gastrorrhagia Market Performance (Volume)
  • 3.1.3 Pancreatitis Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Merck
  • 4.1.1 Merck Profiles
  • 4.1.2 Merck Product Information
  • 4.1.3 Merck Somatostatin Business Performance
  • 4.1.4 Merck Somatostatin Business Development and Market Status
• 4.2 Sanofi
  • 4.2.1 Sanofi Profiles
  • 4.2.2 Sanofi Product Information
  • 4.2.3 Sanofi Somatostatin Business Performance
  • 4.2.4 Sanofi Somatostatin Business Development and Market Status
• 4.3 Lyomark Pharma
  • 4.3.1 Lyomark Pharma Profiles
  • 4.3.2 Lyomark Pharma Product Information
  • 4.3.3 Lyomark Pharma Somatostatin Business Performance
  • 4.3.4 Lyomark Pharma Somatostatin Business Development and Market Status
• 4.4 ALFA WASSERMANN
  • 4.4.1 ALFA WASSERMANN Profiles
  • 4.4.2 ALFA WASSERMANN Product Information
  • 4.4.3 ALFA WASSERMANN Somatostatin Business Performance
  • 4.4.4 ALFA WASSERMANN Somatostatin Business Development and Market Status
• 4.5 Polypeptide Laboratories
  • 4.5.1 Polypeptide Laboratories Profiles
  • 4.5.2 Polypeptide Laboratories Product Information
  • 4.5.3 Polypeptide Laboratories Somatostatin Business Performance
  • 4.5.4 Polypeptide Laboratories Somatostatin Business Development and Market Status
• 4.6 SAMARTH
  • 4.6.1 SAMARTH Profiles
  • 4.6.2 SAMARTH Product Information
  • 4.6.3 SAMARTH Somatostatin Business Performance
  • 4.6.4 SAMARTH Somatostatin Business Development and Market Status
• 4.7 UBPL
  • 4.7.1 UBPL Profiles
  • 4.7.2 UBPL Product Information
  • 4.7.3 UBPL Somatostatin Business Performance
  • 4.7.4 UBPL Somatostatin Business Development and Market Status
• 4.8 TianTaiShan
  • 4.8.1 TianTaiShan Profiles
  • 4.8.2 TianTaiShan Product Information
  • 4.8.3 TianTaiShan Somatostatin Business Performance
  • 4.8.4 TianTaiShan Somatostatin Business Development and Market Status
• 4.9 Yangtze
  • 4.9.1 Yangtze Profiles
  • 4.9.2 Yangtze Product Information
  • 4.9.3 Yangtze Somatostatin Business Performance
  • 4.9.4 Yangtze Somatostatin Business Development and Market Status
• 4.10 SIYAO
  • 4.10.1 SIYAO Profiles
  • 4.10.2 SIYAO Product Information
  • 4.10.3 SIYAO Somatostatin Business Performance
  • 4.10.4 SIYAO Somatostatin Business Development and Market Status
• 4.11 ShuangCheng
• 4.12 TianTaiShan
• 4.13 Lyomark Pharma
• 4.14 ALFA WASSERMANN
• 4.15 Polypeptide Laboratories

5 Market Performance for Manufacturers

• 5.1 Europe Somatostatin Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Somatostatin Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Somatostatin Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Somatostatin Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Somatostatin Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Somatostatin Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Somatostatin Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Somatostatin Market Performance (Sales Point)

• 7.1 Europe Somatostatin Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Somatostatin Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Somatostatin Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Somatostatin Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Somatostatin Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Cancer Industry
• 11.2 Gastrorrhagia Industry
• 11.3 Pancreatitis Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Somatostatin Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Somatostatin Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Somatostatin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 0.1 mg Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 0.25 mg Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 0.6 mg Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 2 mg Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Cancer Sales and and Growth Rate 2019-2024
  • 12.4.3 Gastrorrhagia Sales and and Growth Rate 2019-2024
  • 12.4.4 Pancreatitis Sales and and Growth Rate 2019-2024
  • 12.4.5 Others Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Somatostatin Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Somatostatin Gross Profit Trend 2019-2024

13 Conclusion